MENU

Are Afterpay and these shares the best buy and hold options on the ASX?

I think that one of the best ways for investors to beat the market over the long-term is to invest in quality shares with strong businesses and equally strong growth prospects.

The good news for investors is that there are a number of shares that tick these boxes right now. Three ASX shares that I think would be great buy and hold options are listed below. Here’s why I would buy them:

Afterpay Touch Group Ltd (ASX: APT)

I think Afterpay Touch’s shares could be a fantastic buy and hold investment option for investors with a high tolerance for risk. I’ve been very impressed at the way the company’s buy now, pay later platform has started life in the U.S. and believe it is a sign that the platform could replicate its Australian success in a market which is many, many times larger. If the company can build on this and succeed in the UK market as well, then I believe there’s a strong probability that its shares will generate above-average returns for shareholders over the next decade.

CSL Limited (ASX: CSL)

I would class CSL as the ultimate buy and hold share on the Australian share market. The biotherapeutics giant has been one of the best performers on the market over the last decade, providing investors with an average annual total return of 21.9%. Pleasingly, I believe the company is well-positioned to continue this positive form over the next decade thanks to its strong core business, expanding plasma collection network, and lucrative pipeline of products under development.

ResMed Inc (ASX: RMD)

Another top buy and hold option could be this medical device company. ResMed is focused on creating innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The company aims to achieve this through its portfolio of cloud-connected medical devices which care for people with sleep apnoea, chronic obstructive pulmonary disease, and other chronic diseases. Like CSL, ResMed has been an impressive performer over the last 10 years and provided an average total return of 19.7% per annum. Due to the quality of its products and the expanding addressable market, I believe ResMed is well-positioned to continue being a market beater over the next decade.

And finally, here are three more buy-rated shares that could be great long term investments.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!